CA2030344A1 - Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines - Google Patents

Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines

Info

Publication number
CA2030344A1
CA2030344A1 CA2030344A CA2030344A CA2030344A1 CA 2030344 A1 CA2030344 A1 CA 2030344A1 CA 2030344 A CA2030344 A CA 2030344A CA 2030344 A CA2030344 A CA 2030344A CA 2030344 A1 CA2030344 A1 CA 2030344A1
Authority
CA
Canada
Prior art keywords
treatment
keto
pulmonary dysfunction
prostaglandin compounds
dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2030344A
Other languages
English (en)
Other versions
CA2030344C (fr
Inventor
Ryuji Ueno
Hiroyoshi Osama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Publication of CA2030344A1 publication Critical patent/CA2030344A1/fr
Application granted granted Critical
Publication of CA2030344C publication Critical patent/CA2030344C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002030344A 1989-11-22 1990-11-20 Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines Expired - Lifetime CA2030344C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30384189 1989-11-22
JP303841/1989 1989-11-22

Publications (2)

Publication Number Publication Date
CA2030344A1 true CA2030344A1 (fr) 1991-05-23
CA2030344C CA2030344C (fr) 2000-04-18

Family

ID=17925951

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002030344A Expired - Lifetime CA2030344C (fr) 1989-11-22 1990-11-20 Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines

Country Status (5)

Country Link
EP (1) EP0430552B1 (fr)
KR (1) KR0153779B1 (fr)
AT (1) ATE129895T1 (fr)
CA (1) CA2030344C (fr)
DE (1) DE69023459T2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739343B2 (en) * 1997-11-28 2001-10-11 Sucampo Ag Endothelin antagonist
EP1220849B1 (fr) † 1999-10-15 2004-05-19 Sucampo AG Composition de composes bicycliques et procede pour sa stabilisation
MXPA04002006A (es) 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
TWI263505B (en) 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
US20070203228A1 (en) * 2006-02-28 2007-08-30 Sucampo Ag Method for treating chronic obstructive pulmonary disease
JP2012528077A (ja) * 2009-05-27 2012-11-12 スキャンポ・アーゲー クローディン媒介機能の調節および皮膚疾患の処置に使用するための、プロスタグランジン誘導体を含む医薬組成物
US8569279B2 (en) 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764699A (en) * 1971-12-02 1973-10-09 American Home Prod Methods for relieving bronchial spasm with prostaglandin-f{11 and derivatives
DE2328132A1 (de) * 1973-05-30 1975-01-02 Schering Ag Neue prostansaeurederivate und verfahren zu ihrer herstellung
JPS58164512A (ja) 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
JPS5973522A (ja) 1982-10-20 1984-04-25 Dainippon Pharmaceut Co Ltd 脳神経細胞の酸素欠乏性疾患治療剤
JPS58203911A (ja) 1982-05-25 1983-11-28 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
EP0153858A3 (fr) * 1984-02-29 1985-12-11 The Upjohn Company Application thérapeutique de prostaglandines
EP0310305B1 (fr) 1987-10-02 1992-07-22 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Cathartiques
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
ES2055051T3 (es) * 1988-05-23 1994-08-16 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para la fabricacion de un medicamento eficaz para aumentar la presion sanguinea.
DK0391218T3 (da) * 1989-04-04 1996-07-29 Beiersdorf Ag Middel til forebyggelse af atopi

Also Published As

Publication number Publication date
DE69023459D1 (de) 1995-12-14
KR910009271A (ko) 1991-06-28
EP0430552B1 (fr) 1995-11-08
EP0430552A3 (en) 1992-07-01
CA2030344C (fr) 2000-04-18
DE69023459T2 (de) 1996-04-04
KR0153779B1 (ko) 1998-11-16
ATE129895T1 (de) 1995-11-15
EP0430552A2 (fr) 1991-06-05

Similar Documents

Publication Publication Date Title
DK0379979T3 (fr)
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
CA2150251A1 (fr) Lyospheres contenant de la gonadotropine
CA2041417A1 (fr) Traitement d'une maladie du pancreas a l'aide de composes de 15-ceto-prostaglandine
CA2040248A1 (fr) Methode d'inhibition de la secretion d'acide gastrique
CA2062653A1 (fr) Promotion de la cicatrisation avec des composes a base de 15-cetoprostaglandine
CA2046069A1 (fr) Traitement des maladies inflammatoires au moyen de composes de 15-cetoprostaglandine
CA2029657A1 (fr) Compositions pharmaceutiques permettant de reduire la tension intra-oculaire et mode d'utilisation
CA2135614A1 (fr) Utilisation de l'urodilatine pour les affections pulmonaires et bronchiques
NZ232946A (en) Preparation of crystalline 17alpha-hydroxy-7alpha methyl-19-nor-17-pregn-5
PT84041A (en) Process for the preparation of optically pure s-(-)-1-propyl-2:,6:-pipecoloxylidide hydrochloride monohydrate and of pharmaceutical compositions containing the same
CA2027814A1 (fr) Traitement d'une maladie hepatobiliaire a base de composes 5-cetoprostaglandin
CA2069608A1 (fr) Derives de substitution de 4-phenylpiperidine-4-carboxamides ayant des effets anesthesiques et analgesiques locaux; methode de preparation
CA2030344A1 (fr) Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines
CA2179733A1 (fr) Sulfamates de pseudofructopyranose anticonvulsifs
CA2063273A1 (fr) Surfactants pulmonaires et methodes
CA2042934A1 (fr) Traitement de l'hypertension oculaire au moyen d'une combinaison synergique oculaire
CA2114859A1 (fr) Compose cytotoxique et antiviral
AU4897790A (en) (-)-N"-Cyano-N-3-pyridyl-N'-1,2,2-trimethyl- propylguanidine, a process for preparing the compound, and use of the compound as a medicament
CA2042937A1 (fr) Traitement de l'hypertension oculaire au moyen d'une combinaison synergique
CA2007261A1 (fr) Nouveaux derives de tetraline
AU5992990A (en) 14,17alpha-etheno- and -ethanoestratrienes, processes for the preparation of these compounds, as well as their use for the production of medicinal agents
CA2030346A1 (fr) Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines
CA2041240A1 (fr) Traitement biochimique a l'aide de 15-deshydroxy-16-oxoprostaglandine
CA2048245A1 (fr) Traitement de la cataracte avec des composes a base de prostacycline

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry